Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$32.9 - $47.0 $16,450 - $23,500
500 Added 1.8%
28,300 $940,000
Q1 2024

May 15, 2024

SELL
$41.76 - $74.73 $513,648 - $919,179
-12,300 Reduced 30.67%
27,800 $1.33 Million
Q4 2023

Feb 14, 2024

SELL
$58.16 - $75.44 $1.08 Million - $1.4 Million
-18,600 Reduced 31.69%
40,100 $2.96 Million
Q3 2023

Nov 14, 2023

BUY
$70.9 - $88.63 $2.33 Million - $2.91 Million
32,800 Added 126.64%
58,700 $4.29 Million
Q2 2023

Aug 14, 2023

BUY
$81.09 - $94.16 $948,753 - $1.1 Million
11,700 Added 82.39%
25,900 $2.15 Million
Q1 2023

May 15, 2023

SELL
$82.98 - $91.46 $4.42 Million - $4.87 Million
-53,300 Reduced 78.96%
14,200 $1.27 Million
Q4 2022

Feb 14, 2023

SELL
$66.93 - $97.5 $1.13 Million - $1.64 Million
-16,810 Reduced 19.94%
67,500 $5.78 Million
Q3 2022

Nov 14, 2022

BUY
$69.86 - $107.63 $1.05 Million - $1.62 Million
15,090 Added 21.8%
84,310 $6.03 Million

Others Institutions Holding QDEL

About QuidelOrtho Corp


  • Ticker QDEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 66,952,900
  • Market Cap $2.68B
  • Description
  • QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...
More about QDEL
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.